A61P 21 - Drugs for disorders of the muscular or neuromuscular system

Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
12/2011
12/13/2011	USRE43029 Process for preparing a creatine heterocyclic acid salt and method of use
12/13/2011	CA2539070C Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
12/13/2011	CA2470743C Corticotropin releasing factor 2 receptor agonists
12/13/2011	CA2358520C Soluble receptor br43x2 and methods of using
12/08/2011	WO2011153277A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
12/08/2011	WO2011152618A2 Non-diffusive botulinum toxin causing local muscle paralysis, and purification method thereof
12/08/2011	WO2011152524A1 Cell growth-promoting peptide and use thereof
12/08/2011	WO2011151632A1 Dietary formulations
12/08/2011	WO2011151432A1 Humanised antigen binding proteins to myostatin6
12/08/2011	WO2011097456A3 Compositions and methods for enhanced parvovirus transduction
12/08/2011	US20110301218 MODIFIED snRNAs FOR USE IN THERAPY
12/08/2011	US20110301210 Use of pramipexole to treat amyotrophic lateral sclerosis
12/08/2011	US20110301203 Chemical compounds
12/08/2011	US20110301149 Compositions and methods for treating alcohol use disorders, pain and other diseases
12/08/2011	US20110301133 Compositions of protein receptor tyrosine kinase inhibitors
12/08/2011	US20110301128 Pyrrole Derivatives As Pharmaceutical Agents
12/08/2011	US20110301097 Oral Administration Of Therapeutic Agent Coupled To Transporting Agent
12/08/2011	US20110301096 Prodrug of an ice inhibitor
12/08/2011	US20110301075 Use of BBI/BBIC for Treatment of Muscular Atrophy and Degenerative Muscle Disease
12/08/2011	US20110300149 Ljungan virus
12/08/2011	CA2801802A1 Humanised antigen binding proteins to myostatin6
12/08/2011	CA2801224A1 Dietary formulations
12/07/2011	EP2392660A2 ENA Nucleic Acid Drugs Modifying Splicing in mRNA Precursor
12/07/2011	EP2392350A1 Methods for treating conditions associated with MASP-2 dependent complement activation
12/07/2011	CN102271701A 具有脂类动员性质的糖蛋白及其治疗用途 Glycoprotein lipid mobilizing its therapeutic use have properties
12/07/2011	CN102266176A 一种药草保健床垫床褥 Herb health mattress mattress
12/07/2011	CN101904969B 一种治疗增生性疾病的中药组合物及其制备方法 Chinese medicinal composition and preparation method for the treatment of proliferative diseases
12/07/2011	CN101780226B 一种治疗骨伤的膏药 A treatment for bone-setting plaster
12/06/2011	US8071729 Anti-integrin antibodies, compositions, methods and uses
12/06/2011	US8071635 Minimal cardivascular and/or sedatory activity; treating pain and allodynia; selective to alpha2B and/or alpha2C adrenergic receptors in preference over alpha2A adrenergic receptors;
12/06/2011	US8071550 Treating hyperplasic, hypertonic, cystic and/or neoplastic uterine gland tissue by local administration of a botulinum toxin or Clostridual neurotoxin
12/06/2011	US8071549 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival cells
12/06/2011	US8071538 Method of increasing muscle mass by administering a myostatin binding agent
12/06/2011	US8071333 Anti-integrin antibodies, compositions, methods and uses
12/06/2011	US8071110 Activatable clostridial toxins
12/06/2011	US8071096 Anti-C5aR antibodies and uses thereof
12/06/2011	CA2541813C Methods for treating acute and overuse sprain and strain using hyaluronic acid
12/01/2011	WO2011150008A1 Antibodies to human gdf8
12/01/2011	WO2011147967A1 Skeletal muscle regeneration using mesenchymal stem cells
12/01/2011	WO2011147086A1 Microvesicles carrying small interfering rnas, preparation methods and uses thereof
12/01/2011	US20110294858 Substituted 6-methylnicotinamides as mglur5 positive allosteric modulators
12/01/2011	US20110294856 Novel oxadiazole derivatives and their medical use
12/01/2011	US20110294825 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/01/2011	US20110294824 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/01/2011	US20110294781 Pyrazolo-pyrimidine compounds
12/01/2011	US20110294771 Treatment of muscular dystrophy
12/01/2011	US20110294753 Means and methods for counteracting muscle disorders
12/01/2011	US20110294742 Degradable clostridial toxins
12/01/2011	US20110294734 Pharmaceutical compositions comprising tgf-beta 1 inhibitor peptides
12/01/2011	US20110294720 Apratoxin therapeutic agents: mechanism and methods of treatment
12/01/2011	US20110293715 Pharmaceutical Formulation and Process for Its Preparation
12/01/2011	US20110293699 Hydrogel implants with varying degrees of crosslinking
12/01/2011	US20110293667 Bioengineered Tissue Constructs and Methods for Producing and Using Thereof
12/01/2011	US20110293663 Pharmaceutical botulinum toxin compositions
12/01/2011	US20110293630 Antibodies to Human GDF8
12/01/2011	US20110293612 Method for the Treatment of Neurodegenerative Diseases
12/01/2011	US20110293610 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
12/01/2011	US20110293599 Method for modulating muscle differentiation or regeneration
12/01/2011	US20110293564 2-morpholino-pyrido[3,2-d]pyrimidines
12/01/2011	CA2800581A1 Antibodies to human gdf8
11/2011
11/30/2011	EP2389180A1 Methods of treating muscular dystrophies
11/30/2011	EP1938824B1 Medicine, food and drink or feed containing sphingomyelin
11/30/2011	CN102264379A 肌肉增强剂 Muscle enhancer
11/30/2011	CN102258667A 一种治疗痹症的中药组合物 A therapeutic herbal composition arthralgia
11/30/2011	CN102258588A 芍药总苷的制备方法 Preparation of total glucosides of peony
11/30/2011	CN102258578A 新颖的荷叶总生物碱提取物及其制备方法和用途 Novel lotus total alkaloid extract and its preparation method and use
11/30/2011	CN102258575A 一种治疗肩周炎的膏药及其制备方法 A frozen treat plaster and its preparation method
11/30/2011	CN102258531A 一种含有环磷腺苷与葡甲胺的药物组合物及其制备方法 An meglumine cyclic adenosine monophosphate and pharmaceutical compositions containing its preparation method
11/30/2011	CN102258496A 溴吡斯的明缓释片剂及其制备方法 Ming-release tablets pyridostigmine bromide and its preparation method
11/30/2011	CN102258492A 溴新斯的明缓释片剂及其制备方法 Ming-release tablets bromine neostigmine and its preparation method
11/30/2011	CN101972413B 一种治疗面瘫的中药 A treatment of facial paralysis medicine
11/30/2011	CN101843801B 一种透骨活血止痛酊 One kind Speranskia Huoxuezhitong tincture
11/30/2011	CN101632663B 神经毒性的分子靶 Molecular targets neurotoxicity
11/29/2011	US8067575 RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)
11/29/2011	US8067453 Oxazole compound to treat or prevent diabetic neuropathy; 4-(4-chlorophenyl)-5-(3-(2-methoxyphenoxy)propyl-2-methyl-1-imidazolyl)oxazole
11/29/2011	US8067396 Amino alcohol compounds or phosphonic acid derivatives thereof
11/29/2011	US8067392 Compositions and methods for treatment of mitochondrial diseases
11/29/2011	US8067381 Methods and compositions for increasing the anaerobic working capacity in tissues
11/29/2011	US8067001 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/29/2011	DE202011001708U1 Kosmetisches Polymer-Gel mit heilender Wirkung Cosmetic polymer gel with healing properties
11/29/2011	CA2624935C Anti-myostatin antibodies
11/29/2011	CA2473634C 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
11/29/2011	CA2453843C Substituted 4-aminocyclohexanol derivatives
11/24/2011	WO2010134047A3 Liquid dosage forms of isotretinoin
11/24/2011	US20110288158 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
11/24/2011	US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
11/24/2011	US20110288122 Pharmaceutical Compositions and Administrations Thereof
11/24/2011	US20110288060 apparatus and process for producing crystals
11/24/2011	US20110287048 Antigen Specific Tregs and related compositions, methods and systems
11/24/2011	US20110287026 Sirt4 and uses thereof
11/24/2011	US20110287004 Mg53 compositions and methods of use
11/24/2011	US20110286986 Lactoferrin and angiogenin compositions and uses thereof
11/24/2011	US20110286959 Copolymers for suppression of autoimmune diseases, and methods of use
11/24/2011	US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells
11/24/2011	CA2800109A1 Methods for inhibiting muscle atrophy
11/23/2011	EP2388263A1 Imidazo[2,1-b]thiazole derivatives as sirtuin modulators
11/23/2011	EP1915140B1 Novel use of peptide compounds for treating muscle pain
11/23/2011	EP1467976B1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
11/23/2011	CN102256942A New polymorphic form of 1- (4- { l- [ (e) -4-cyclohexyl--3-trifluoromethyl-benzyloxyimino] -ethyl) -2-ethyl-benzy l) -azetidine-3-carboxylic
11/23/2011	CN102256941A New salts

1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 233